Skip to main content
Premium Trial:

Request an Annual Quote

Lawrence Tech University Lands $3M Gift for Life Sciences and Molecular Medicine Institute

NEW YORK (GenomeWeb News) – Lawrence Technological University in southeastern Michigan has received an anonymous $3 million gift to expand its life sciences program, to fund research programs and establish an institute of molecular medicine, and to support research programs that include functional proteomics studies of type II diabetes, LTU said Monday.
 
LTU biology Professor Hsiao-Ping Moore, who studies proteomics and cell signaling, is planning the expansion, LTU said.
 
Separately, Moore is using federal funds in a collaboration with Wayne State University scientist James Granneman to study the proteins involved in the links between type II diabetes and obesity. That research is supported by the National Institutes of Health, the American Diabetes Association, and Veterans Administration Hospitals.
 
In addition to the anonymous gift, which LTU said it received this summer, the university also will use a $1 million endowment to support the life sciences and biomedical engineering expansion.
 
LTU was not immediately available to provide more information about the origin of the anonymous gift or the endowment, or more specifics about its planned molecular medicine institute.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.